| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 192 |
| 1 | FUROSEMIDE | 138 |
| 2 | ASPIRIN | 116 |
| 3 | ASPIRIN 325 MG | 116 |
| 4 | ASPIRIN 81 MG | 116 |
| 5 | BISOPROLOL FUMARATE | 82 |
| 6 | CYCLOPHOSPHAMIDE | 65 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 65 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 65 |
| 9 | OLANZAPINE | 61 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 41 | 0.0178 |
| 1 | PRAZOSIN HYDROCHLORIDE | 7 | 0.0050 |
| 2 | NIZATIDINE | 6 | 0.0039 |
| 3 | AMISULPRIDE | 23 | 0.0038 |
| 4 | DESLORATADINE | 22 | 0.0020 |
| 5 | CLOZAPINE | 192 | 0.0015 |
| 6 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 5 | 0.0015 |
| 7 | BENZTROPINE | 10 | 0.0013 |
| 8 | VALPROATE SODIUM | 28 | 0.0013 |
| 9 | OXAZEPAM | 28 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 241 |
| 1 | Corticosteroid [EPC] | 175 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 170 |
| 3 | Loop Diuretic [EPC] | 144 |
| 4 | Benzodiazepine [EPC] | 142 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 118 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 108 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 107 |
| 8 | Proton Pump Inhibitor [EPC] | 95 |
| 9 | Alkylating Drug [EPC] | 73 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 23 | 0.0039 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 23 | 0.0029 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 107 | 0.0011 |
| 3 | Atypical Antipsychotic [EPC] | 241 | 0.0005 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 51 | 0.0004 |
| 5 | General Anesthetic [EPC] | 18 | 0.0004 |
| 6 | Aldosterone Antagonist [EPC] | 60 | 0.0004 |
| 7 | Catecholamine [EPC] | 30 | 0.0004 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 49 | 0.0004 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 16 | 0.0003 |